Covance Company Profile (NYSE:CVD)

About Covance (NYSE:CVD)

Covance logoCovance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:CVD
  • CUSIP: 22281610
  • Web:
Average Prices:
  • 50 Day Moving Avg: $97.00
  • 200 Day Moving Avg: $82.00
  • 52 Week Range: $58.00 - $107.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 21.20
  • P/E Growth: 0
  • Net Margins: 7.70%
  • Return on Equity: 12.64%
  • Return on Assets: 8.17%
  • Average Volume: 187,762 shs.

Frequently Asked Questions for Covance (NYSE:CVD)

What is Covance's stock symbol?

Covance trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVD."

How were Covance's earnings last quarter?

Covance Inc. (NYSE:CVD) announced its quarterly earnings results on Wednesday, February, 4th. The company reported $0.97 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.97. The business had revenue of $634 million for the quarter, compared to analyst estimates of $631.30 million. Covance had a return on equity of 12.64% and a net margin of 7.70%. View Covance's Earnings History.

Who are some of Covance's key competitors?

How do I buy Covance stock?

Shares of Covance can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Covance's stock price today?

One share of Covance stock can currently be purchased for approximately $106.00.

MarketBeat Community Rating for Covance (NYSE CVD)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  163 (Vote Underperform)
Total Votes:  285
MarketBeat's community ratings are surveys of what our community members think about Covance and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Covance (NYSE:CVD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Covance (NYSE:CVD)
Price Target History for Covance (NYSE:CVD)
Analysts' Ratings History for Covance (NYSE:CVD)
No equities research coverage for this company has been tracked by


Earnings History for Covance (NYSE:CVD)
Earnings by Quarter for Covance (NYSE:CVD)
Earnings History by Quarter for Covance (NYSE CVD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/4/2015Q414$0.97$0.97$631.30 million$634.00 millionViewN/AView Earnings Details
11/3/2014Q314$0.98$0.98$651.00 million$627.00 millionViewN/AView Earnings Details
7/29/2014Q214$0.93$0.95$639.80 million$687.10 millionViewN/AView Earnings Details
5/1/2014Q114$0.90$0.90$632.01 million$620.10 millionViewN/AView Earnings Details
2/4/2014Q413$0.84$0.87$613.80 million$623.00 millionViewN/AView Earnings Details
7/30/2013Q2 2013$0.77$0.78$586.12 million$644.00 millionViewN/AView Earnings Details
5/1/2013Q1 2013$0.72$0.75$569.34 million$580.20 millionViewN/AView Earnings Details
1/24/2013Q4 2012$0.71$0.73$548.84 million$562.20 millionViewN/AView Earnings Details
11/5/2012Q312$0.67$0.72$546.52 million$597.66 millionViewN/AView Earnings Details
7/25/2012$0.64$0.65ViewN/AView Earnings Details
5/2/2012$0.60$0.68ViewN/AView Earnings Details
1/25/2012$0.73$0.73ViewN/AView Earnings Details
11/2/2011$0.70$0.71ViewN/AView Earnings Details
7/27/2011$0.65$0.66ViewN/AView Earnings Details
5/5/2011$0.58$0.60ViewN/AView Earnings Details
1/26/2011$0.53$0.56ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Covance (NYSE:CVD)
Current Year EPS Consensus Estimate: $4 EPS
Next Year EPS Consensus Estimate: $5 EPS


Dividend History for Covance (NYSE:CVD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Covance (NYSE:CVD)
Insider Trades by Quarter for Covance (NYSE:CVD)
Insider Trades by Quarter for Covance (NYSE:CVD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/22/2014Brian H NuttInsiderSell1,127$103.51$116,655.77View SEC Filing  
12/18/2014Joseph L HerringCEOSell32,692$103.02$3,367,929.84View SEC Filing  
12/10/2014John E WatsonVPSell15,200$102.94$1,564,688.00View SEC Filing  
9/9/2014Joseph L HerringCEOSell32,200$85.13$2,741,186.00View SEC Filing  
2/20/2014James LovettVPSell14,955$102.47$1,532,438.85View SEC Filing  
2/10/2014Brian NuttInsiderSell1,808$100.12$181,016.96View SEC Filing  
2/10/2014Richard CiminoEVPSell13,000$99.10$1,288,300.00View SEC Filing  
2/10/2014Sandra HeltonDirectorSell2,800$99.03$277,284.00View SEC Filing  
9/20/2013Richard CiminoEVPSell16,000$84.86$1,357,760.00View SEC Filing  
9/5/2013Sandra L HeltonDirectorSell3,000$81.92$245,760.00View SEC Filing  
9/5/2013William E KlitgaardVPSell25,323$81.44$2,062,305.12View SEC Filing  
8/21/2013Deborah KellerEVPSell15,900$83.12$1,321,608.00View SEC Filing  
8/16/2013Robert BarchiDirectorSell13,667$82.78$1,131,354.26View SEC Filing  
8/2/2013Gary CostleyDirectorSell7,467$82.77$618,043.59View SEC Filing  
8/2/2013Joseph HerringCEOSell100,000$82.54$8,254,000.00View SEC Filing  
6/27/2013Joseph L HerringCEOSell13,259$77.00$1,020,943.00View SEC Filing  
6/19/2013Joseph L HerringCEOSell22,391$78.03$1,747,169.73View SEC Filing  
5/15/2013James W LovettVPSell10,259$77.00$789,943.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Covance (NYSE:CVD)
Latest Headlines for Covance (NYSE:CVD)
Loading headlines, please wait.



Covance (CVD) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.